Continuing management
| Hospital Variation | ||||
| n (%) | IQR % | Range % | ||
| PEF chart record | 51 | (710) | 28–68 | 5–93 |
| FEV1 or PEF recorded | 71 | (988) | 58–84 | 26–93 |
| Inhaler technique assessed | 20 | (241/1218) | 4–26 | 0–90 |
| Smoking cessation advice given: | ||||
| to smokers | 30 | (134/445) | 14–45 | 0–75 |
| to exsmokers in last months | 11 | (7/64) | 0–0 | 0–50 |
| Pa,O2>7.3 kPa on air at any time | 33 | (455) | 18–48 | 0–78 |
| OP follow-up | 63 | (797/1272) | 50–80 | 22–94 |
| Vaccination advice given | 5 | (65) | 0–7 | 0–21 |
| Pulmonary rehabilitation recommended | 3 | (39) | 0–3 | 0–39 |
| Reversibility to bronchodilator | 27 | (378) | 6–38 | 0–86 |
| Steroid reversibility tested | 7 | (96) | 0–11 | 0–44 |
| Discharge medication | ||||
| Inhaled bronchodilator | 64 | (899) | 48–80 | 28–100 |
| Long-acting bronchodilator | 15 | (209) | 5–18 | 0–69 |
| Inhaled steroid | 56 | (779) | 45–68 | 14–84 |
| Oral steroid | 57 | (803) | 47–71 | 7–80 |
| Home nebuliser | 38 | (536) | 30–48 | 0–86 |
| Home oxygen | 18 | (254) | 10–25 | 3–40 |
| Theophylline | 24 | (340) | 15–35 | 0–50 |
| Antibiotics | 35 | (493) | 29–40 | 5–78 |
Stated as concentrator in 105 cases and as cylinder in 90
PEF: peak expiratory flow
FEV1: forced expiratory volume in one second
Pa,O2: arterial oxygen tension
OP: outpatient.